Figure 7

Effects of Tocotrienol-Rich Fraction (TRF) supplementation on escape latencies across treatment groups throughout the 5 day reversal phase. Data expressed as mean ± SD (n = 10). *P < 0.001, **P < 0.01 and ***P < 0.05 denotes significant difference from the control group.